Market evolution: Fracture splints (CN 90211090) — 2015–2025

Introduction

This report examines the European Union's external trade in splints and other fracture appliances (customs code 90211090) over the period 2015–2025. This product category falls under orthopaedic and fracture appliances and covers a wide range of medical devices used in trauma care, orthopaedic rehabilitation, and post-surgical recovery. The period under review spans a decade of structural transformation in the global medical-device supply chain, shaped by ageing populations, the COVID-19 pandemic, and shifting trade relationships. EU domestic production in this segment roughly doubled over the period, reaching an estimated €3.5 billion by 2025, yet trade flows grew even faster, revealing an increasingly internationally integrated market.

1. Robust and Broad-Based Growth Across Both Trade Flows

The 2015–2025 period was characterised by strong, sustained expansion in both EU imports and exports of fracture splints, with trade values more than doubling on both sides.

1.1. Import and export values both more than doubled

EU imports rose from €464 million in 2015 to €1,127 million in 2025 (+142.7%), while exports grew from €371 million to €929 million (+150.4%). Both flows therefore expanded at broadly similar rates in value terms, though the EU has remained a net importer throughout.

1.2. Import volumes grew much faster than export volumes

The divergence in volume growth is striking. Import quantities more than doubled, rising from 1,881 tonnes to 3,902 tonnes (+107.4%), whereas export volumes grew more modestly from 1,328 tonnes to 1,870 tonnes (+40.8%). This means the EU imported nearly twice as much physical product by 2025 as it did in 2015, while export volumes increased by less than half. The gap between the two flows widened considerably in mass terms.

1.3. Export prices rose far more steeply than import prices

A key structural feature of this market is the diverging price trajectory. Average export prices climbed from €279,380 per tonne to €496,828 per tonne (+77.8%), while import prices rose only from €246,875 to €288,932 per tonne (+17.0%). This suggests the EU specialises increasingly in higher-value-added fracture appliances for export — consistent with its position as a producer of premium orthopaedic devices — while importing growing volumes of more standardised products at lower unit prices.

2. Shifting Geographies of Trade: New Supply Chains and Diversifying Destinations

The partner-country data reveals a significant reconfiguration of both the EU's sourcing and its export destinations over the decade, with some partners seeing explosive growth and others losing relative ground.

2.1. The United States remains the dominant partner on both sides

The United States was by far the largest bilateral partner in both directions. EU imports from the US grew from €237 million to €496 million (+109.4%), while EU exports to the US surged from €102 million to €389 million (+280.3%). The US thus absorbed a growing share of EU exports — its share roughly tripled over the period — reflecting the attractiveness of the US orthopaedic market for European manufacturers.

2.2. Switzerland and Mexico emerged as fast-growing import sources

EU imports from Switzerland grew from €142 million to €431 million (+204.0%), making Switzerland the second-largest import source by 2025. This likely reflects the role of Swiss-based medtech companies (e.g., DePuy Synthes/J&J, Medacta, others) that manufacture in Switzerland and sell into the EU. Mexico saw even faster growth (+331.3%), rising from €15 million to €66 million, a sign that nearshoring and cost-competitive manufacturing in North America are becoming more important in the fracture-appliance supply chain.

2.3. Vietnam's emergence signals a broader supply-chain shift

Perhaps the most dramatic change was Vietnam, where EU imports surged from just €66,000 in 2015 to nearly €8.0 million in 2025 — a staggering +11,970% increase. While still a small absolute share, this growth is consistent with the broader trend of medical-device manufacturing migrating to Southeast Asian countries, partly as a "China+1" diversification strategy adopted by multinational companies after the supply-chain disruptions of the COVID-19 pandemic.

2.4. Export destinations diversified, with Japan and Australia rising sharply

On the export side, the EU's traditional reliance on the US and UK was complemented by rapid growth in Asian and Pacific markets. Exports to Japan grew from €28 million to €101 million (+262.1%), and exports to Australia rose from €7 million to €26 million (+249.8%). Exports to South Africa also expanded from €7 million to €22 million (+214.6%). These trends suggest EU manufacturers are successfully penetrating markets with ageing demographics and growing orthopaedic needs beyond the transatlantic corridor.

2.5. The United Kingdom's role diminished on the import side

EU imports from the UK fell by 28.9% (from €20.6 million to €14.6 million), and the UK also showed the highest import volatility (coefficient of variation of 1.18). This decline, and its elevated volatility, is consistent with the disruptions and regulatory divergence introduced by Brexit, which added friction to UK–EU medical-device trade from 2020 onward.

3. From Self-Sufficiency to Growing Import Dependence

A defining structural shift over this decade is the EU's transition from near self-sufficiency in fracture splints to meaningful import reliance, accompanied by growing trade intensity and internal concentration shifts.

3.1. Net import reliance surged from near zero to 17%

The EU's net import reliance — defined as the trade deficit relative to apparent consumption — rose from just 1.6% in 2015 to 16.6% in 2025, a +954% increase. At its peak, the metric reached nearly 30%. This means that whereas the EU was nearly balanced in its fracture-appliance trade in 2015, it now depends on extra-EU suppliers for roughly one-sixth of its consumption. The widening gap between fast-growing import volumes (+107%) and slower export volumes (+41%) underpins this shift.

3.2. Trade intensity and export propensity both climbed steeply

Trade intensity — the sum of imports and exports relative to production — rose from 44.6% to 69.7% (+56.5%). Export propensity — exports relative to production — climbed from 28.1% to 48.9% (+74.0%). The EU's fracture-splint market is therefore increasingly open and globally integrated: by 2025, nearly half of domestic production was exported, and the total trade footprint (imports plus exports) approached 70% of production value. This is a significant structural change from a decade ago, when the market was considerably more self-contained.

3.3. The Netherlands and Ireland stand out as the most transformed EU economies

Among EU member states, the Netherlands saw the most dramatic shifts. Dutch imports grew from €166 million to €536 million (+223%), and Dutch exports exploded from €45 million to €286 million (+530%), making the Netherlands the EU's second-largest exporter by 2025. This reflects the country's role as a major logistics hub and the presence of significant medical-device distribution operations. Ireland's imports surged from €3.9 million to €44.5 million (+1,042%) and its exports from €2.5 million to €25.2 million (+904%), consistent with Ireland's growing medtech manufacturing base. Germany remained the EU's largest exporter at €438 million in 2025, though its export concentration (HHI) rose, suggesting greater reliance on key destination markets.

3.4. Export concentration increased while import sources diversified slightly

The Herfindahl-Hirschman Index for exports by value rose from 1,383 to 2,087 (+50.9%), indicating that EU exports became more concentrated in fewer destination countries — primarily the United States. In contrast, the import HHI declined slightly from 3,719 to 3,470 (−6.7%), suggesting a modest diversification of import sources. The combination of rising export concentration and slightly declining import concentration implies that the EU is becoming more exposed to demand-side risk in key export markets while marginally reducing supply-side risk through source diversification.

3.5. Sporadic price shocks hint at procurement vulnerabilities

The volatility analysis detected notable price shocks in EU exports. The most significant was an 830% price spike in exports to the United Kingdom centred on 2019, with an abnormality score of 41.3. Similar, though less extreme, price shocks were detected for exports to Norway (+583%, 2019) and Japan (+34%, 2020). These events may reflect one-off contract shifts, reclassification effects, or pandemic-related supply disruptions. On the import side, Vietnam and Bosnia and Herzegovina exhibited the highest volatility (CVs of 0.76 and 1.38 respectively), reflecting the early-stage, small-scale nature of these trade relationships rather than systemic instability.

Conclusion

The EU fracture-splint market underwent a profound transformation between 2015 and 2025. Trade values more than doubled on both the import and export sides, but the underlying dynamics diverged: import volumes surged (+107%) while export values were driven more by price increases (+78% unit price growth) than by volume expansion. The EU shifted from near self-sufficiency to a net import reliance of 17%, even as domestic production roughly doubled to an estimated €3.5 billion. The geographic landscape also evolved — the United States consolidated its position as the dominant bilateral partner, Switzerland and Mexico became critical import sources, and EU exporters found growing success in Japan, Australia, and South Africa. Meanwhile, the UK's role in EU supply chains diminished post-Brexit, and Vietnam emerged as a small but rapidly growing supplier. The key challenge for the coming years will be managing the growing concentration of EU exports in a handful of markets — particularly the US — while continuing to diversify import sources to mitigate supply-chain risk.